KCNA3 and autoimmune glomerulonephritis: Moreover, rats injected with the small-molecule KV1.3 blocker Psora-4 showed less proteinuria and fewer crescentic glomeruli [70], suggesting the potential role of KV1.3 toxin peptides in the treatment of autoimmune glomerulonephritis.